Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High Flow Oxygen for Migraine in the ED
NCT04925414Phase 4Recruiting
- Sponsor
- Centre Hospitalier Universitaire de Nice
- Start
- Oct 2023
- Primary completion
- Apr 2025
- Modality
- Inhalation Devices
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial in migraine comparing Oxygenotherapy with Placebo Air (2 arms). Primary endpoint: Pain evaluation at 30 minutes. Started Oct 2023; status: recruiting.
02
Drugs
oxygen
03
Conditions
migraine
Beyond the preview
Go deeper on NCT04925414.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04925414.